Oregon Public Employees Retirement Fund’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$439K Sell
52,499
-1,200
-2% -$10.9K ﹤0.01% 1280
2026
Q1
$484K Sell
53,699
-700
-1% -$11K 0.01% 1189
2025
Q4
$992K Buy
54,399
+600
+1% +$10.1K 0.01% 858
2025
Q3
$789K Sell
53,799
-600
-1% -$10.3K 0.01% 960
2025
Q2
$991K Buy
54,399
+293
+0.5% +$5.97K 0.02% 786
2025
Q1
$1.07M Sell
54,106
-1,494
-3% -$25.8K 0.02% 728
2024
Q4
$954K Buy
55,600
+700
+1% +$13.2K 0.02% 818
2024
Q3
$1.1M Buy
+54,900
New +$854K 0.02% 757

Other funds holding ADMA

Oregon Public Employees Retirement Fund's ADMA Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund reduced its ADMA Biologics (ADMA) stake by 2.2% in Q2 2026, selling an estimated $10.9K and leaving 52,499 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Oregon Public Employees Retirement Fund first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.1M in Q3 2024. 131 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 52,499 shares of ADMA Biologics worth $439K as of Q2 2026.
  • Oregon Public Employees Retirement Fund sold 1,200 ADMA Biologics shares in Q2 2026, an estimated $10.9K.
  • ADMA Biologics made up ﹤0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1280 holding.
  • Oregon Public Employees Retirement Fund first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • Oregon Public Employees Retirement Fund's ADMA Biologics position peaked at $1.1M in Q3 2024.
  • 131 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.